spasticity


Also found in: Thesaurus, Medical, Idioms, Encyclopedia, Wikipedia.

spas·tic

 (spăs′tĭk)
adj.
1. Of, relating to, or characterized by spasms: a spastic colon; a spastic form of cerebral palsy.
2. Affected by spastic paralysis.
3. Offensive Slang Clumsy or inept.
n.
A person affected with spastic paralysis.

[Latin spasticus, from Greek spastikos, from spān, to pull.]

spas′ti·cal·ly adv.
spas·tic′i·ty (spă-stĭs′ĭ-tē) n.
American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.

spasticity

(spæsˈtɪsɪtɪ)
Collins English Dictionary – Complete and Unabridged, 12th Edition 2014 © HarperCollins Publishers 1991, 1994, 1998, 2000, 2003, 2006, 2007, 2009, 2011, 2014
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.spasticity - the quality of moving or acting in spasms
fitfulness, jerkiness - the quality of being spasmodic and irregular
Based on WordNet 3.0, Farlex clipart collection. © 2003-2012 Princeton University, Farlex Inc.
Translations
spasticité

spasticity

[spæsˈtɪsɪtɪ] Nespasticidad f
Collins Spanish Dictionary - Complete and Unabridged 8th Edition 2005 © William Collins Sons & Co. Ltd. 1971, 1988 © HarperCollins Publishers 1992, 1993, 1996, 1997, 2000, 2003, 2005

spasticity

Collins German Dictionary – Complete and Unabridged 7th Edition 2005. © William Collins Sons & Co. Ltd. 1980 © HarperCollins Publishers 1991, 1997, 1999, 2004, 2005, 2007

spas·tic·i·ty

n. espasticidad, aumento en la tensión normal de un músculo que causa movimientos rígidos y dificultosos.
English-Spanish Medical Dictionary © Farlex 2012

spasticity

n espasticidad f
English-Spanish/Spanish-English Medical Dictionary Copyright © 2006 by The McGraw-Hill Companies, Inc. All rights reserved.
References in periodicals archive ?
Food and Drug Administration (FDA) approved the company's supplemental biologics application (sBLA) for BOTOX[R] for the treatment of pediatric patients (2 to 17 years of age) with upper limb spasticity. BOTOX[R] was granted a six-month Priority Review by the FDA, which is typically granted to therapies that if approved, could offer significant improvements in safety and effectiveness when compared to current standard of care.
Food and Drug Administration (FDA) approved the company's supplemental biologies application (sBLA) for BOTOX[R] for the treatment of pediatric patients (2 to 17 years of age) with upper limb spasticity. BOTOX[R] was granted a six-month Priority Review by the FDA, which is typically granted to therapies that if approved, could offer significant improvements in safety and effectiveness when compared to current standard of care.
M2 EQUITYBITES-June 24, 2019-Allergan wins US FDA approval for sBLA of prescription medicine BOTOX for treating paediatric patients with upper limb spasticity
Global Banking News-June 24, 2019-Allergan wins US FDA approval for sBLA of prescription medicine BOTOX for treating paediatric patients with upper limb spasticity
M2 PHARMA-June 24, 2019-Allergan wins US FDA approval for sBLA of prescription medicine BOTOX for treating paediatric patients with upper limb spasticity
OS440-3004 was a double-blind placebo-controlled study in which multiple sclerosis patients with documented muscular spasticity in any limb received placebo, 40 mg arbaclofen per day, or 80 mg arbaclofen per day.
15, 2018 (HealthDay News) -- Cannabinoids may be mildly effective at treating spasticity, pain, and bladder dysfunction in adults with multiple sclerosis (MS), according to a review published online Oct.
The 13 abstracts will present neuroscience data that advances knowledge in physical and rehabilitation medicine including clinical outcomes linked to Ipsen's portfolio in adult spasticity (upper and lower limbs), pediatric spasticity, and in cervical dystonia.
They completed a 75-item questionnaire, which included questions from a validated tool called the Patient Reported Impact of Spasticity Measure (PRISM).
A European Thematic Network to Develop Standardised Measures of Spasticity suggested the following definition: "Spasticity is an interrupted or constant hyperactivity of the skeletal muscles, caused by lesions of the upper motor neuron" [1].